‘This Has Cost Millions of Lives’: Steve Kirsch on Suppression of Repurposed Drugs and a Spike in Deaths 5 Months After Vaccine Rollout
American Thought Leaders - Podcast tekijän mukaan Jan Jekielek
Sponsor special: Up to $2,500 of FREE silver AND a FREE safe on qualifying orders - Call 855-862-3377 or text “AMERICAN” to 6-5-5-3-2“The clue was the embalmers. The clue was the insurance companies. The embalmers never saw anything until midway in 2021. And then they started seeing these massive clots … It only started six months into the vaccination program,” says Steve Kirsch, the executive director of the Vaccine Safety Research Foundation.Kirsch argues there are two peaks of vaccine-related mortality: one is within weeks of vaccination, and one is about five or six months after vaccination.A successful entrepreneur and philanthropist, Kirsch has started a number of high-tech companies, including one of the first Internet search engines, Infoseek, and he is also one of two people who independently invented the optical mouse. During the COVID-19 pandemic, he founded the COVID-19 Early Treatment Fund and raised millions of dollars to fund outpatient clinical trials for repurposed drugs.“When I started speaking out against the vaccine, within a week, all 14 members of [my] scientific advisory board quit,” Kirsch says.We discuss the suppression of repurposed drugs like fluvoxamine, perverse hospital incentives, and the bewildering lack of institutional interest in looking at data on vaccine-related injuries and deaths.“Everybody’s drinking the Kool-Aid, and these vaccine-injured people are paying the price,” Kirsch says.